As genetic engineering and DNA manipulation tools like CRISPR continue to advance, the distinction between what science ‘could’ and ‘should’ do becomes murkier.

Microbes that safely break down antibiotics could prevent opportunistic infections and reduce the spread of antibiotic resistance.

Researchers create a mathematical framework to examine the genome and detect signatures of natural selection, deciphering the evolutionary past and future of non-coding DNA.

MIT engineers design the first synthetic circuit that consists entirely of fast, reversible protein-protein interactions.

Computational algorithms enable identification and optimization of RNA-based tools for myriad applications.

A 3D printing system that controls the behavior of live bacteria could someday enable medical devices with therapeutic agents built in.

Chemical engineers program bacteria to switch between different metabolic pathways, boosting their yield of desirable products.

A new easy-to-use legal tool that enables exchange of biological material between research institutes and companies launches today.